[HK IPO] 7 new stocks are hitting the market at the same time, which one will be the next big winner?

Today is World Bear Day, so the drop is justified (not really;

Don't want to talk about the secondary market anymore... The pace of Hong Kong stock IPOs has been very tight recently, with 7 stocks coming to market at once. For the five from last Friday, I might consider Huayan Robot, but because two more were listed today, I need to think about how to allocate funds.First, let's talk about the absolute C-position of this round: Huayan Robot. Fundamental Analysis

Looking at the financial data, the gross margin performance is very strong, rising all the way to 37.6%. The company's revenue CAGR reached 68.4%. However, entering 2025, the year-on-year revenue growth rate for the first 9 months has dropped from 77% in 2024 to about 36%, indicating the high-growth phase may have peaked. Overall, this is a company whose fundamentals are in the first tier within its sector, and it's the only one already profitable at scale, with continuously improving gross margins and solid in-house R&D capabilities for core components.Now let's talk about the others

Hantian Tiancheng: Makes silicon carbide epitaxial wafers, a hard-tech player in semiconductor materials, an industry leader, but its performance and valuation are a headache.
Tongrentang Medical Care: Focuses on traditional Chinese medicine healthcare. Although backed by a century-old brand and sounds stable, the valuation is too expensive. Plus, the precedent of the other two companies in the same group breaking their issue price makes me want to steer clear!
Deshi-B: Claims to be the first stock in the medical imaging large model sector, operating in the AI healthcare track. Despite its loud concept, it has no cornerstone investors and no greenshoe, and it's an unprofitable 18A target.
Extreme Vision: A company that does AI computer vision, listed under 18C. It has the lowest minimum subscription fee, which is very friendly for small investors, and the concept is good. However, its cash flow has some issues, so I'll wait to see the margin financing data first.

Finally, let's talk separately about the two new listings today
Tong Shifu: Based on the issue market cap, both the PE and PS ratios are quite high. Moreover, there's only one cornerstone investor locking in 6.6%, so the price support capability is negligible.Fourier: In a nutshell, it's "all that glitters is not gold." It's continuously losing money, has no cornerstone investors, and has various issues like patent lawsuits that are debatable.

The final strategy is still to wait until I look at both companies in detail before deciding.

Follow Vivian for continuous analysis of Hong Kong and US stock market trends